Published strains in the Culture Collection
| Species | CCOS | Strain | Feature | Publication |
| Arsenicicoccus dermatophilus | 690T | KM 894/11 |
Type strain Isolated from skin from the feet of Phoenicopterus roseus with pododermatitis |
Gobeli et al. 2013 |
| Arsenicicoccus dermatophilus | 691 | KM 1/12 | Isolated from skin from the feet of Phoenicopterus roseus with pododermatitis | Gobeli et al. 2013 |
| Aggregatibacter actinomycetemcomitans | 193 | ZIB 1023 | contains phage AaΦ23 | Resch G. et al. 2004 |
| Aggregatibacter actinomycetemcomitans | 192 | ZIB 1001 | lysogenic for phage AaΦ23 | Willi K., Sandmeier H., Meyer J. 1993. Med. Microbiol. Lett. 2:419-26 |
| Aspergillus oryzae | 827 | P 2190 (Baden) |
alpha-amylase producing strain from wort (Brewery H. Mueller AG, Baden, Switzerland |
Joseph Meyrath, 1957 |
| Bacteroides thetaiotaomicron | 632 | ARABA 84 | Indicator strain used to detect human faecal contamination in spring water due to bacteriophage lysis | Wicki M. et al. 2011 |
| Erwinia gerundensis | 903T | EM595T |
Type strain Presence of a chromosomal carotenoid biosynthesis gene cluster |
Rezzonico F. et al. 2016 |
| Escherichia coli | 684 | KK77/1, serotype O76:H51 | attaching and effacing Escherichia coli (AEEC) reference strain used for adhesion (HEp-2 cells), isolated from feces of healthy children, intimin type γ, carries an EAF plasmid with bfp gene, encoding bundle-forming pili, strong FAS (fluorescent actin staining) response | Beutin et al. 2003 |
| Glaciimonas alpina | 761T | CR9-12T, DSM 22814 |
Type strain Isolated from alpine glacier cryconite |
Frasson D. et al. 2015 |
| Lactococcus lactis subsp. lactis | 1 | K214 | streptomycin-, tetracycline- and chloramphenicol-resistance genes on plasmid pK214 | Perreten V. et al. 1997 |
| Leucobacter chromiiresistens | 200T | JG 31 |
Type strain Chromate resistant |
Sturm G. et al. 2011 |
| Methylobacterium extorquens | 32 | OS8 | Degradation of formaldehyde | Di Maiuta N. et al. 2009 |
| Pantoea agglomerans | 338 | ACW 55802 | proposed as new subspecies | Rezzonico F. et al. 2009 |
| Proteus mirabilis | 487 | HK223 | rifampicin resistant recipient strain used in conjugation transfer experiments | Suenderhauf U. et al. 1976 |
| Pseudomonas aeruginosa | 692 | PAO372 | teaching strain lysine and arginine auxotroph, UV mutagenic killing and DNA repair |
Sobrero P. and Valverde C. 2012 Haas et al. 1977 |
| Pseudomonas protegens | 2T | CHA0, DSM 19095 |
Type strain Production of antifungal metabolites |
Stutz E.W. et al. 1986 |
| Pseudomonas protegens | 223 | Pf-5 | complete genome sequenced | Paulsen I.T. et al. 2005 |
|
Pseudomonas fluorescens |
546 | CHA77 | ΔhcnABC, no production of HCN | Laville J. et al. 1998 |
| Pseudomonas kilonensis/brassicacearum | 190 | G11 | cyanide HCN formation | Zeller S.L. et al. 2007 |
| Pseudomonas reidholzensis | 865 | CCOS 865T, LMG 29328T | Type strain, isolated in Switzerland, gelatinase activity | Frasson et al. 2017 |
|
Pseudomonas sp. closely related to P. soli |
191 | Zurich | cyanogenic phosphate solubilizing | Smits T.H.M. et al. 2015 |
| Pseudomonas wadenswilerensis | 864T |
CCOS 864T, LMG 29327T |
Type strain, isolated in Switzerland, gelatinase activity | Frasson et al. 2017 |
| Salmonella enterica serovar Typhimurium | 514 | SKI22 | M525P ΔnanA ΔwaaI ΔwaaB terminal glucose in the lipid A core |
Ilg K. et al. 2010 |
| Saccharomyces cerevisiae | 538 | LBG H1022, LBG H620, ATCC 32167 | hydrophilic surface properties (water contact angle 27°) cultivation in a vertical microbubble column |
Tybussek R. et al. 1994 Rieger M. et al. 1983 Demming S. et al. 2012 |
| Saccharomyces cerevisiae | 887 | NMY32 | Yeast 2-Hybrid System | Lentze N. et al. 2008 |
| Saccharomyces cerevisiae | 888 | NMY51 | Yeast 2-Hybrid System | Lentze N. et al. 2008 |
| Saccharomyces cerevisiae | 889 | NMY61 | Yeast 2-Hybrid System | Lentze N. et al. 2008 |
| Staphylococcus aureus | 43 | Bern100 (KM595-06) |
diagnostic strain | Panchaud Y. et al. 2010 |
| Staphylococcus aureus | 168 | MSSA 1112 | methicillin-susceptible S. aureus, MSSA | Entenza J.M. et al. 2004 Entenza J.M. et al. 1997 |
| Staphylococcus aureus | 66 | CHE482 | methicillin-resistant, new SCCmec element | Ender M. et al. 2007 |
| Staphylococcus aureus | 198 | CQ66 | Markerless deletion of secDF (Sec translocation protein machinery) from strain Newman by allelic replacement | Quiblier C. et al. 2011 |
| Staphylococcus aureus | 199 | BB1000, strain Newman, NCTC 8178, ATCC 25904, CCUG 54581, CCM 2773 | isolated from a case of secondarily infected tubercular osteomyelitis in man strong free-coagulase producer |
|
| Staphylococcus aureus | 593 | MRGR3 | human bloodstream isolate with methicillin, vancomycin, fleroxacin, and rifampin MICs of >64, 1, 0.62 and 0.01 ug/ml, respectively | Lucet J.C. et al. 1990 Renzoni A. et al. 2009 |
| Staphylococcus aureus | 662 | UAMS-155 UAMS-1, agr::tetM |
mutation of the accessory gene regulator agr resulted in, biofilm formation comparable to UAMS-1 | Beenken K.E. et al. 2010 |
| Staphylococcus aureus | 663 | UAMS-929 UAMS-1, sarA::kan |
mutation of staphylococcal accessory regulator (sarA) resulted in a reduced capacity to form a biofilm and increased production of extracellular proteases and extracellular nucleases | Beenken K.E. et al. 2010 |
| Staphylococcus aureus | 664 | UAMS-1653 UAMS-1625, sarA::tetK |
mutation of staphylococcal accessory regulator (sarA) resulted in a reduced capacity to form a biofilm and increased production of extracellular proteases and extracellular nucleases | Beenken K.E. et al. 2010 |
| Staphylococcus aureus | 665 | UAMS-1660 UAMS-1625, agr::tetM |
mutation of the accessory gene regulator agr resulted in, biofilm formation comparable to UAMS-1 | Beenken K.E. et al. 2010 |
| Staphylococcus aureus | 666 |
UAMS-1625 |
MRSA, isolated from a patient with a fatal brain abscess, USA, Biofilm formation,absence of the arginine catabolite metabolic element (ACME), resistance to penicillin, ampicillin-sulbactam, oxacillin, and erythromycin | Beenken K.E. et al. 2010 Sifri C.D. et al. 2007 |
| Staphylococcus aureus | 667 | UAMS-1 | MSSA, isolated from the bone of a patient suffering from osteomyelitis, Little Rock, Arkansas, USA UAMS-1 is a collagen adhesin gene(cna)-positive osteomyelitis isolate that encodes fibronectin binding adhesin fnbA but not fnbB, hypervirulent in a mice model of musculoskeletal infection, biofilm formation |
Cassat J.E. et al. 2005 Beenken K.E. et al. 2010 Blevins J.S. et al. 2003 Blevins J.S. et al. 2002 Gillaspy A.F. et al. 1995 |
| Staphylococcus aureus | 890 | JAR 06.01.31 | Human periprostethic knee biopsy, used in orthopedic implants rat models | Stadelmann et al. 2014 |
| Staphylococcus pseudintermedius | 39 | KM1381 | Dog, fistula after surgery resistant against: methicillin, chloramphenicol, enrofloxacin, clindamycin, erythromycin, gentamicin, streptomycin, trimethoprim-sulfamethoxazole, tetracycline |
Descloux S. et al. 2008 |
| Staphylococcus pseudintermedius | 38 | KM241 | Ear of a dog suffering from otitis externa resistant against: methicillin, new SCCmecVII, tetracycline (tetM) MRSP |
Descloux S. et al. 2008 |
| Staphylococcus pseudintermedius | 475 | ST71, strain 27366 | First case of human infection with ST71 resistant against: amoxicillin, clindamycin, enrofloxacin, erythromycin, gentamicin, kanamycin, oxacillin, penicillin, streptomycin, tetracycline, trimethoprim, contains SCCmec II-III |
Stegmann R. et al. 2010 |
|
Streptococcus tigurinus |
600T | AZ_3a |
Type strain Isolated from the blood culture of a patient with endocarditis |
Zbinden A. et al., 2012
|